Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Which ventilator keeps oxygen levels steadier during hospital transport?

NCT ID NCT07198269

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares two types of ventilators (breathing machines) used when moving patients who are on life support within or between hospitals. The goal is to see if a new ventilator (TV80) keeps oxygen levels as stable as a standard one (HAMILTON-T1). About 98 adults will be randomly assigned to one ventilator or the other, and their oxygen levels and vital signs will be measured before and after transport.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 98 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Dec 2025

An estimate. Start dates often move.

Expected to finish

Jun 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Aged ≥ 18 years and \< 80 years. * Patients receiving invasive mechanical ventilation. * Patients requiring intra-hospital transport or inter-hospital transfer. * Patients whose legal representatives have provided written informed consent for participation in the trial. Exclusion Criteria: * Subjects with shock or hemodynamic instability that has not been treated * Subjects receiving high-dose vasopressor support (equivalent norepinephrine dose \> 1µg/kg/min) * Patients receiving ECMO support * Subjects with hemoglobin \< 6g/dL * Subjects with cardiac arrest without resuscitation treatment * Patients who are moribund or discharged due to deteriorating condition * Patients with bullae, pneumothorax without closed thoracic drainage, especially tension pneumothorax * Massive hemoptysis, and respiratory failure caused by massive hemoptysis or severe aspiration * Pregnant and lactating women * Patients with mental illness * Subjects whose legal representatives have not provided informed consent * Patients without access to trial ventilators during the trial, including when trial ventilators are in use or malfunctioning * Expected transport duration exceeding 1 hour or combined transport scenarios (helicopter combined with ambulance)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Patients receiving invasive mechanical ventilation are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • 2 nd Affiliated Hospital, School of Medicine, Zhejiang University, China

    Hangzhou, Zhejiang, 310009, China